Farms.com Home   News

June Canola Crush Up Only Slightly from May

The Canadian canola crush was little changed in June compared to a month earlier, as processing continued to slow into the end of the old-crop marketing year. 

A Statistics Canada crush report Monday showed Canadian oilseed processors crushed 772,345 tonnes of canola last month, up only marginally from 769,942 tonnes in May and the second least since the August 2022 crush of 632,962. However, the June crush was still up nearly 17% from the same month last year after Prairie drought slashed the 2021 Canadian canola crop by about one-third.  

 With just slightly more than one full month to go before the official end of the 2022-23 marketing year on Aug. 31, the total crush now stands at 9.05 million tonnes, 16.3% ahead of the previous year’s pace and roughly 95% of Agriculture Canada’s full year crush forecast of 9.5 million – up 1 million from 2021-22.  

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.